Paper Details
- Home
- Paper Details
Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.
Author: IJzermanNikki S, MathijssenRon H J, ReynersAnna K L, SteeghsNeeltje, de HaanJacco J, van ElstJip M
Original Abstract of the Article :
Taste, smell, and mouthfeel disturbances are underrated and underreported, but important side effects of anti-cancer medication. These symptoms are associated with a lower quality of life (QoL). The prevalence and the impact of taste, smell, and mouthfeel disturbances on daily life in patients with ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s00520-021-06658-z
データ提供:米国国立医学図書館(NLM)
Taste, Smell, and Mouthfeel: Underestimated Side Effects of GIST Treatment
Imagine a camel caravan navigating a vast desert, the journey punctuated by the tantalizing scents of spices and the satisfying taste of dates. However, some travelers might experience disruptions to their senses, diminishing the joys of the journey. This study explores the often-overlooked side effects of taste, smell, and mouthfeel disturbances in patients with gastrointestinal stromal tumors (GIST) undergoing tyrosine-kinase inhibitor therapy.
The Hidden Impact of Cancer Treatment
This research reveals that taste, smell, and mouthfeel disturbances are common side effects of GIST treatment, significantly impacting patients' quality of life. These sensory disruptions can significantly alter daily life, affecting enjoyment of food and overall well-being.
Improving the Patient Experience
This study emphasizes the need for greater awareness and understanding of these often-underreported side effects. By acknowledging and addressing these sensory disturbances, we can improve the quality of life for GIST patients undergoing tyrosine-kinase inhibitor therapy.
Dr.Camel's Conclusion
The desert of cancer treatment can be harsh, and it's important to recognize all the challenges faced by patients. This research sheds light on the often-overlooked sensory disturbances that can significantly impact patients' quality of life, reminding us that compassionate care must address the full spectrum of a patient's experience.
Date :
- Date Completed 2022-01-31
- Date Revised 2022-01-31
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.